Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 21:00:00 22/04/2026 BST			5-day change	1st Jan Change
21.01 ^USD	-2.55%		+0.43%	+6.38%

04-14	Alignment Healthcare Insider Sold Shares Worth $6,161,943, According to a Recent SEC Filing	MT
04-08	Alignment Healthcare Insider Sold Shares Worth $5,252,911, According to a Recent SEC Filing	MT

Analyst Reco.

01-14	UBS Adjusts Alignment Healthcare Price Target to $21 From $18, Maintains Neutral Rating	MT
31/10/25	UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating	MT
25/08/25	Alignment Healthcare's Strong Medicare Advantage Model Supports Better Results, Higher Savings, KeyBanc Says	MT
25/08/25	KeyBanc Upgrades Alignment Healthcare to Overweight From Sector Weight, Price Target is $21	MT
30/07/25	Alignment Healthcare Q2 revenue beats estimates; co raises annual outlook	RE
02/05/25	UBS Adjusts Alignment Healthcare Price Target to $17 From $16, Maintains Neutral Rating	MT
28/02/25	UBS Adjusts Price Target on Alignment Healthcare to $16 From $12, Keeps Neutral Rating	MT
03/12/24	Stephens Upgrades Alignment Healthcare to Overweight From Equalweight, Price Target is $17	MT
30/10/24	UBS Adjusts Price Target on Alignment Healthcare to $12 From $9, Maintains Neutral Rating	MT
11/10/24	KeyBanc Initiates Alignment Healthcare at Sector Weight	MT
02/08/24	UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating	MT
30/05/24	BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75	MT
30/05/24	Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target	MT
08/05/24	Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral	MT
03/05/24	UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating	MT
23/04/24	Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating	MT
06/03/24	Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12	MT
28/02/24	UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating	MT
24/01/24	Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target	MT
09/01/24	Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating	MT
21/12/23	UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating	MT
02/11/23	BofA Securities Downgrades Alignment Healthcare to Neutral From Buy	MT
16/10/23	Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9	MT
12/10/23	Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target	MT
30/08/23	Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating	MT